ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

29 hedge funds and large institutions have $2.3M invested in Albireo Pharma, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.

Holders
29
Holders Change
-4
Holders Change %
-12.12%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
8
Closed
5
Calls
$28K
Puts
–
Net Calls
+$28K
Net Calls Change
+$38K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.12M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$480K
3
Deutsche Bank
3
Deutsche Bank
Germany
$68K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$12K
5
UBS Group
5
UBS Group
Switzerland
$6K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$318K
2
BC
2
Broadfin Capital
New York
$0
3
SM
3
Sabby Management
Florida
$118K
4
Nomura Holdings
4
Nomura Holdings
Japan
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$4K
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– – -739 Closed
AIM
27
Advantage Investment Management
Iowa
$0 250 – –
Creative Planning
28
Creative Planning
Kansas
$0 150 – –
Bank of America
29
Bank of America
North Carolina
$0 742 – –
LTFS
30
Ladenburg Thalmann Financial Services
Florida
$0 1,000 – –
Acadian Asset Management
31
Acadian Asset Management
Massachusetts
$0 1,154 – –
PMFA
32
Plante Moran Financial Advisors
Michigan
$0 1,470 – –
Morgan Stanley
33
Morgan Stanley
New York
$0 113 +5 +5%
Citigroup
34
Citigroup
New York
$0 70 +70 New
1
2